The role of anti-VEGF in the management of proliferative diabetic retinopathy and diabetic vitreous haemorrhage
This post will explore the role of anti-VEGF injections in the management of proliferative diabetic retinopathy. It will cover the effect of anti-VEGF on diabetic retinal neovascularization and vitreous haemorrhage. It will also address the common concerns regarding the use of anti-VEGF in proliferative disease, including the risk of tractional retinal detachment (crunch) and the danger in loss to follow up.
Insight from DRCR.net protocol W and PANORAMA study for non-proliferative diabetic retinopathy
This is a discussion of the role of anti-VEGF injections in the treatment of moderate to severe non-proliferative diabetic retinopathy without macula oedema
Research, Opinions and Practice News
This section contains regular updates on the latest research in retinal diseases, and our opinion on their management.
I hope you find this informative. If it is useful to you, please consider subscribing to our newsletter so you can be informed of any new blog posts.